Banner

Rosemary and hesperidin alleviate cardiac dysfunction and alter cellular signaling pathways in experimental model of diabetic cardiomyopathy

BENHA VETERINARY MEDICAL JOURNAL • 2022
Back
Publication Information
Authors Samy A. Hussein, Omayma A.R. AboZaid, Hussein A. Ali, Tahya E.A. Ismael, Ghada F. Al lawaty
Keywords Diabetic cardiomyopathy, hesperidin, PPAR-γ, rosemary extract, SERCA
Journal BENHA VETERINARY MEDICAL JOURNAL
Publisher Faculty of Vet.Medicine
Volume 42
Issue 2
Pages 37-42
publication.type Local
Paper Link Open Link
Supplementary Materials Not Available
Abstract
Alterations in the cardiac structure and function are the hallmarks of diabetic cardiomyopathy (DCM), separate coronary heart disease in diabetic patients. In a streptozotocin-induced diabetic rat model, the current research aimed to investigate the preventive effects of rosemary extract and hesperidin on DCM. Fifty male Rats were divided into five main groups. Group Ι: rats received no drugs. Group Π: STZ (50 mg/kg b.wt.) was given intraperitoneally (i.p.) to rats just once. Group III: Rats treated with insulin at a dose of (2 U/rat/day). Group IV: rats treated with Rosemary extract at a dose of (200 mg/kg b.wt. /day). Group V: rats treated with Hesperidin at a dose of (100 mg/kg b.wt./day). The results showed a marked increase in serum total cholesterol and triacylglycerol concentrations and downregulation in Peroxisome proliferator-activated receptor-γ (PPAR-γ) and Sarcoplasmic reticulum Ca2+-ATPase (SERCA) genes expressions with upregulation in Collagen type IV (COL4) in cardiac tissue of DCM-induced group. Treatment with insulin, rosemary extract, or hesperidin to STZ-induced DCM in rats exhibited a substantial reduction in the levels of triacylglycerol and total cholesterol with an enormous downregulation of COL4 gene expression level in cardiac tissue. However, PPAR-γ and SERCA genes exhibited an enormous upregulation. In conclusion, the results indicated that rosemary extract and hesperidin have a beneficial effect in preventing lipid metabolic disorders and diabetes complications and modify several genes such as PPAR-γ, SERCA, and COL4 participating in cellular pathways which altered in DCM.